NXGLNexGel Inc Common Stock

0.3300USD-18.30%Mkt Cap: 3.22M $P/E:

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It oper…

HeadlineSourceTime
Older
NEXGEL Q2 Revenue Reaches $3.69 Million as BioNX Integration Faces Slower Ramp

NEXGEL (NASDAQ:NXGL) reported second-quarter 2026 revenue of $3. 69 million and a net loss of $2.

InvestorsHub